Search results
Tango terminates USP1 inhibitor programme
Clinical Trials Arena via Yahoo Finance· 11 hours agoThe company’s market cap stands at $757.5m. Tango also planned to evaluate its therapy in combination with AstraZeneca’s and Merck & Co’s poly-ADP ribose...
Madison-based life science company Mirus Bio to be acquired for $600 million
Small Business Times· 1 day agoMadison-based Mirus Bio, a manufacturer of transfection regents used in gene therapies, has entered...
HPV vaccine provides real benefits for men, analysis shows By Reuters
Investing.com· 24 hours agoHPV vaccine provides real benefits for men, analysis shows
Why billion-dollar music fund Hipgnosis hit a bum note: ‘Songs are not gold and oil’
The Telegraph via Yahoo Finance· 2 days ago“I would absolutely love to own the Beatles catalogue,” Merck Mercuriadis told me back in 2021. At...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks· 3 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Big Funds Bet the ‘Anything But Bonds’ Trade Is Poised to End
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Big US bond investors have been aggressively shifting money into long-dated notes,...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance· 4 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond | The Motley Fool
The Motley Fool· 9 hours agoPer the research of Wharton professor Jeremy Siegel, stocks have outperformed bonds, gold, and the...
Ignorance isn't bliss
Santa Maria Sun· 5 days agoJohn Donegan is fortunate that, as far as I know, there are no state laws that make it a crime to be ignorant. After all, it’s been almost 50 years since the American Psychiatric Association stopped calling homosexuality a mental illness.
Analysis-Nvidia's split of soaring stock could boost retail investor appeal, Dow chances By Reuters
Investing.com· 1 day agoNvidia (NASDAQ:NVDA)'s plan to split its stock after the stunning rise in the chipmaker's share...
